In this rapidly advancing era, the concept of Society 5.0 has emerged as a driving force […]
Overview: Introduction Six-month review process priority registration expanded PMDA support innovative drug consultation early application feedback […]
Understanding the MAH Japan System In Japan, the Marketing Authorization Holder (MAH) is central in the […]
Japanese Market Opportunities in AI-Driven Elderly Care: Living, Health, and Medication Management The silver economy of […]
The recent regulatory changes in Japan’s pharmaceutical sector present a significant opportunity for non-Japanese companies. By […]
A Thriving Landscape in Japan’s Pharma Sector Pharma Japan and Strategic Opportunities are plentiful in Japan. […]
Japan’s Bioeconomy Strategy 2030 marks a transformative approach to integrating biotechnology into Japan’s economic fabric. It’s […]
It all started with CAR-T cells. Or did it? Dive into the future of biotechnology by […]